Cargando…
Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
BACKGROUND: Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[(18)F]fluoro‐D‐glucose positron emission tomography/computed tomography ([(18)F] FDG‐PET/CT) may be...
Autores principales: | Rizzo, Alessio, Cantale, Ornella, Mogavero, Andrea, Garetto, Lucia, Racca, Manuela, Venesio, Tiziana, Anpalakhan, Shobana, Novello, Silvia, Gregorc, Vanesa, Banna, Giuseppe Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447168/ https://www.ncbi.nlm.nih.gov/pubmed/37442801 http://dx.doi.org/10.1111/1759-7714.15032 |
Ejemplares similares
-
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
por: Anpalakhan, Shobana, et al.
Publicado: (2023) -
1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy
por: Banna, G.L., et al.
Publicado: (2020) -
International Survey on Frailty Assessment in Patients with Cancer
por: Banna, Giuseppe Luigi, et al.
Publicado: (2022) -
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
por: Banna, Giuseppe Luigi, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitors and Opioids in Patients with Solid Tumours: Is Their Association Safe? A Systematic Literature Review
por: Cani, Massimiliano, et al.
Publicado: (2022)